HLB SCIENCE INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3,290 KRW | -0.30% |
|
-4.22% | +28.52% |
More news
| 1 day | -0.30% | ||
| 1 week | -4.22% | ||
| Current month | -24.28% | ||
| 1 month | +32.13% | ||
| 3 months | +60.10% | ||
| 6 months | +87.79% | ||
| Current year | +28.52% |
1 week
3 025.00
3 620.00
1 month
2 350.006 600.00
Current year
1 900.006 600.00
1 year
1 457.006 600.00
3 years
1 457.0015 500.00
5 years
1 457.0015 500.00
10 years
1 457.0015 500.00
| Managers | Title | Age | Since |
|---|---|---|---|
Young-Min Park
CEO | Chief Executive Officer | 63 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Young-Min Park
CEO | Chief Executive Officer | 63 | - |
HLB Science Inc, formerly DanDi Bioscience Inc, is a Korea-based company principally engaged in the research and development of biological pharmaceuticals. The Company is engaged in the research and development of sepsis treatment, antibiotics for super bacteria, dementia treatment, dementia diagnostic kits and other medicines products.
| 1st Jan change | Capi. | |
|---|---|---|
| +28.52% | 39.15M | |
| -3.30% | 102B | |
| +1.79% | 96.07B | |
| -1.19% | 21.66B | |
| -18.35% | 20.77B | |
| -8.33% | 18.53B | |
| -40.31% | 16.91B | |
| -26.84% | 13.79B | |
| +0.59% | 13.33B | |
| +20.86% | 10.94B |
- Stock Market
- Equities
- A343090 Stock
